Clinical Trial

The EMPA-FIT Study

Name: The EMPA-FIT Study — clinical trial record (NCT06846411)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EMPA-FIT

Recruiting Phase 4

View on ClinicalTrials.gov →

Record status

This record was last updated February 26, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

This multicenter, open-label, prospective study randomized 46 drug-naïve adults with T2D (HbA1c 6.5%-10.0%) to receive empagliflozin (10 mg/day) or metformin (1,000 mg/day) for 12 weeks.

Trial Details

NCT Number	NCT06846411
Lead Sponsor	Seoul National University Bundang Hospital
Conditions	Diabetes, Diabetes Mellitus, Type II
Enrollment	46 participants
Start Date	2024-01-01
Primary Completion	2025-09-30 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-26